Structure

Physi-Chem Properties

Molecular Weight:  522.36
Volume:  549.469
LogP:  2.726
LogD:  2.216
LogS:  -3.603
# Rotatable Bonds:  6
TPSA:  138.45
# H-Bond Aceptor:  7
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.315
Synthetic Accessibility Score:  5.442
Fsp3:  0.9
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.264
MDCK Permeability:  4.495308985497104e-06
Pgp-inhibitor:  0.322
Pgp-substrate:  0.271
Human Intestinal Absorption (HIA):  0.016
20% Bioavailability (F20%):  0.054
30% Bioavailability (F30%):  0.858

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.033
Plasma Protein Binding (PPB):  83.93115997314453%
Volume Distribution (VD):  0.528
Pgp-substrate:  8.611515045166016%

ADMET: Metabolism

CYP1A2-inhibitor:  0.005
CYP1A2-substrate:  0.099
CYP2C19-inhibitor:  0.006
CYP2C19-substrate:  0.822
CYP2C9-inhibitor:  0.017
CYP2C9-substrate:  0.215
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.085
CYP3A4-inhibitor:  0.058
CYP3A4-substrate:  0.337

ADMET: Excretion

Clearance (CL):  2.586
Half-life (T1/2):  0.396

ADMET: Toxicity

hERG Blockers:  0.064
Human Hepatotoxicity (H-HT):  0.287
Drug-inuced Liver Injury (DILI):  0.035
AMES Toxicity:  0.031
Rat Oral Acute Toxicity:  0.94
Maximum Recommended Daily Dose:  0.967
Skin Sensitization:  0.418
Carcinogencity:  0.007
Eye Corrosion:  0.004
Eye Irritation:  0.025
Respiratory Toxicity:  0.976

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC200702

Natural Product ID:  NPC200702
Common Name*:   Fasciculol M
IUPAC Name:   (2R,3R,5R,10S,12S,13R,14R,17R)-2,3,12-trihydroxy-4,4,10,13,14-pentamethyl-17-[(2R,5R)-1,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-7-one
Synonyms:  
Standard InCHIKey:  FVNOMENBXLRMPE-YZPVWUHISA-N
Standard InCHI:  InChI=1S/C30H50O7/c1-26(2)21-13-19(32)24-18(28(21,5)14-20(33)25(26)36)12-23(35)30(7)17(10-11-29(24,30)6)16(15-31)8-9-22(34)27(3,4)37/h16-17,20-23,25,31,33-37H,8-15H2,1-7H3/t16-,17+,20+,21-,22+,23-,25-,28+,29-,30-/m0/s1
SMILES:  OC[C@@H]([C@H]1CC[C@@]2([C@]1(C)[C@@H](O)CC1=C2C(=O)C[C@@H]2[C@]1(C)C[C@@H](O)[C@@H](C2(C)C)O)C)CC[C@H](C(O)(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2375633
PubChem CID:   71712506
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33351 naematoloma fasciculare Species Strophariaceae Eukaryota n.a. n.a. n.a. PMID[23634786]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 = 49900.0 nM PMID[481699]
NPT148 Cell Line HCT-15 Homo sapiens IC50 = 8500.0 nM PMID[481699]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 = 7360.0 nM PMID[481699]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 = 4770.0 nM PMID[481699]
NPT81 Cell Line A549 Homo sapiens IC50 = 3990.0 nM PMID[481699]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC200702 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9545 High Similarity NPC136801
0.9205 High Similarity NPC138756
0.9149 High Similarity NPC316964
0.9072 High Similarity NPC323834
0.8901 High Similarity NPC289213
0.8889 High Similarity NPC143767
0.8889 High Similarity NPC131470
0.8878 High Similarity NPC149047
0.8817 High Similarity NPC166906
0.8791 High Similarity NPC86319
0.8791 High Similarity NPC77263
0.8791 High Similarity NPC275740
0.8791 High Similarity NPC250592
0.8788 High Similarity NPC475060
0.8788 High Similarity NPC220229
0.8778 High Similarity NPC99909
0.8776 High Similarity NPC204833
0.8776 High Similarity NPC209502
0.8763 High Similarity NPC473424
0.8723 High Similarity NPC470016
0.8723 High Similarity NPC317586
0.8723 High Similarity NPC473170
0.87 High Similarity NPC217201
0.87 High Similarity NPC65941
0.8696 High Similarity NPC183283
0.8687 High Similarity NPC97202
0.8687 High Similarity NPC214264
0.8687 High Similarity NPC202167
0.8687 High Similarity NPC296945
0.8687 High Similarity NPC150531
0.8687 High Similarity NPC50692
0.8687 High Similarity NPC49958
0.8687 High Similarity NPC302607
0.8687 High Similarity NPC260268
0.8687 High Similarity NPC171137
0.8687 High Similarity NPC152695
0.8687 High Similarity NPC48733
0.8687 High Similarity NPC85829
0.8687 High Similarity NPC319077
0.8687 High Similarity NPC476027
0.8681 High Similarity NPC471722
0.8673 High Similarity NPC191892
0.8667 High Similarity NPC72133
0.8636 High Similarity NPC7988
0.8632 High Similarity NPC328162
0.8632 High Similarity NPC95565
0.8632 High Similarity NPC305483
0.8632 High Similarity NPC96859
0.8632 High Similarity NPC249954
0.8617 High Similarity NPC196485
0.8617 High Similarity NPC245972
0.8614 High Similarity NPC11710
0.8602 High Similarity NPC233116
0.8602 High Similarity NPC155304
0.8602 High Similarity NPC63748
0.86 High Similarity NPC83744
0.86 High Similarity NPC477916
0.8587 High Similarity NPC186688
0.8587 High Similarity NPC32830
0.8571 High Similarity NPC477915
0.8556 High Similarity NPC197823
0.8542 High Similarity NPC320306
0.8526 High Similarity NPC297199
0.8526 High Similarity NPC48330
0.8526 High Similarity NPC255809
0.8526 High Similarity NPC259286
0.8515 High Similarity NPC329417
0.8511 High Similarity NPC69454
0.8485 Intermediate Similarity NPC55872
0.8485 Intermediate Similarity NPC251017
0.8478 Intermediate Similarity NPC328539
0.8454 Intermediate Similarity NPC114274
0.8438 Intermediate Similarity NPC173272
0.8438 Intermediate Similarity NPC471463
0.8438 Intermediate Similarity NPC7124
0.8421 Intermediate Similarity NPC111015
0.8416 Intermediate Similarity NPC165873
0.8409 Intermediate Similarity NPC22403
0.8404 Intermediate Similarity NPC73457
0.8404 Intermediate Similarity NPC185936
0.8404 Intermediate Similarity NPC168027
0.84 Intermediate Similarity NPC28656
0.8387 Intermediate Similarity NPC31985
0.8387 Intermediate Similarity NPC1015
0.837 Intermediate Similarity NPC241875
0.837 Intermediate Similarity NPC469314
0.837 Intermediate Similarity NPC469317
0.837 Intermediate Similarity NPC475740
0.8367 Intermediate Similarity NPC327431
0.8367 Intermediate Similarity NPC157787
0.8367 Intermediate Similarity NPC110149
0.8367 Intermediate Similarity NPC88198
0.8351 Intermediate Similarity NPC170978
0.8351 Intermediate Similarity NPC190554
0.8351 Intermediate Similarity NPC108078
0.8351 Intermediate Similarity NPC43747
0.8351 Intermediate Similarity NPC122294
0.835 Intermediate Similarity NPC76084
0.8333 Intermediate Similarity NPC174948
0.8333 Intermediate Similarity NPC271195
0.8333 Intermediate Similarity NPC318282
0.8333 Intermediate Similarity NPC173875
0.8333 Intermediate Similarity NPC127063
0.8333 Intermediate Similarity NPC469995
0.8317 Intermediate Similarity NPC51452
0.8316 Intermediate Similarity NPC472930
0.8316 Intermediate Similarity NPC25750
0.8316 Intermediate Similarity NPC206810
0.8298 Intermediate Similarity NPC191684
0.8286 Intermediate Similarity NPC73300
0.8286 Intermediate Similarity NPC108721
0.8283 Intermediate Similarity NPC302537
0.8283 Intermediate Similarity NPC163372
0.828 Intermediate Similarity NPC193360
0.828 Intermediate Similarity NPC44181
0.828 Intermediate Similarity NPC53911
0.828 Intermediate Similarity NPC242864
0.828 Intermediate Similarity NPC471724
0.8265 Intermediate Similarity NPC16021
0.8261 Intermediate Similarity NPC474732
0.8261 Intermediate Similarity NPC474733
0.8261 Intermediate Similarity NPC222613
0.8261 Intermediate Similarity NPC474778
0.8261 Intermediate Similarity NPC31564
0.8261 Intermediate Similarity NPC118648
0.8261 Intermediate Similarity NPC145879
0.8261 Intermediate Similarity NPC475022
0.8261 Intermediate Similarity NPC89077
0.8252 Intermediate Similarity NPC214644
0.8247 Intermediate Similarity NPC117133
0.8247 Intermediate Similarity NPC328371
0.8242 Intermediate Similarity NPC473246
0.8235 Intermediate Similarity NPC472925
0.8235 Intermediate Similarity NPC473037
0.8229 Intermediate Similarity NPC472976
0.8229 Intermediate Similarity NPC318332
0.8229 Intermediate Similarity NPC184870
0.8229 Intermediate Similarity NPC472977
0.8229 Intermediate Similarity NPC196227
0.8218 Intermediate Similarity NPC477812
0.8211 Intermediate Similarity NPC19114
0.8211 Intermediate Similarity NPC189520
0.8211 Intermediate Similarity NPC116726
0.82 Intermediate Similarity NPC119601
0.82 Intermediate Similarity NPC308726
0.8191 Intermediate Similarity NPC474245
0.819 Intermediate Similarity NPC207251
0.8182 Intermediate Similarity NPC144660
0.8182 Intermediate Similarity NPC307954
0.8182 Intermediate Similarity NPC299971
0.8182 Intermediate Similarity NPC83709
0.8182 Intermediate Similarity NPC474720
0.8182 Intermediate Similarity NPC15390
0.8182 Intermediate Similarity NPC154072
0.8173 Intermediate Similarity NPC473036
0.8173 Intermediate Similarity NPC272898
0.8173 Intermediate Similarity NPC5284
0.8172 Intermediate Similarity NPC90652
0.8172 Intermediate Similarity NPC58063
0.8163 Intermediate Similarity NPC18509
0.8163 Intermediate Similarity NPC161147
0.8163 Intermediate Similarity NPC18319
0.8152 Intermediate Similarity NPC469948
0.8152 Intermediate Similarity NPC470574
0.8144 Intermediate Similarity NPC472824
0.8144 Intermediate Similarity NPC241156
0.8144 Intermediate Similarity NPC472932
0.8144 Intermediate Similarity NPC472485
0.8144 Intermediate Similarity NPC37646
0.8137 Intermediate Similarity NPC166607
0.8132 Intermediate Similarity NPC476082
0.8132 Intermediate Similarity NPC66764
0.8132 Intermediate Similarity NPC278648
0.8132 Intermediate Similarity NPC110150
0.8125 Intermediate Similarity NPC475255
0.8125 Intermediate Similarity NPC109305
0.8119 Intermediate Similarity NPC471005
0.8119 Intermediate Similarity NPC33973
0.8119 Intermediate Similarity NPC70967
0.8119 Intermediate Similarity NPC264048
0.8119 Intermediate Similarity NPC247957
0.8119 Intermediate Similarity NPC218513
0.8119 Intermediate Similarity NPC249187
0.8119 Intermediate Similarity NPC55954
0.8113 Intermediate Similarity NPC317210
0.8113 Intermediate Similarity NPC250109
0.8113 Intermediate Similarity NPC962
0.8105 Intermediate Similarity NPC48010
0.8105 Intermediate Similarity NPC20388
0.8105 Intermediate Similarity NPC469400
0.81 Intermediate Similarity NPC472924
0.8085 Intermediate Similarity NPC158778
0.8085 Intermediate Similarity NPC470417
0.8081 Intermediate Similarity NPC477854
0.8081 Intermediate Similarity NPC10364
0.8077 Intermediate Similarity NPC286174
0.8077 Intermediate Similarity NPC77947
0.8065 Intermediate Similarity NPC28252
0.8065 Intermediate Similarity NPC94755
0.8065 Intermediate Similarity NPC472491

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC200702 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8587 High Similarity NPD5328 Approved
0.8404 Intermediate Similarity NPD6079 Approved
0.8163 Intermediate Similarity NPD4755 Approved
0.8065 Intermediate Similarity NPD3618 Phase 1
0.8061 Intermediate Similarity NPD5222 Approved
0.8061 Intermediate Similarity NPD5221 Approved
0.8061 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD4697 Phase 3
0.8043 Intermediate Similarity NPD4786 Approved
0.8 Intermediate Similarity NPD5286 Approved
0.8 Intermediate Similarity NPD4700 Approved
0.8 Intermediate Similarity NPD4634 Approved
0.8 Intermediate Similarity NPD4696 Approved
0.8 Intermediate Similarity NPD5285 Approved
0.798 Intermediate Similarity NPD5173 Approved
0.7938 Intermediate Similarity NPD4202 Approved
0.7921 Intermediate Similarity NPD5223 Approved
0.7843 Intermediate Similarity NPD5226 Approved
0.7843 Intermediate Similarity NPD5211 Phase 2
0.7843 Intermediate Similarity NPD5224 Approved
0.7843 Intermediate Similarity NPD5225 Approved
0.7843 Intermediate Similarity NPD4633 Approved
0.7826 Intermediate Similarity NPD3667 Approved
0.7788 Intermediate Similarity NPD7128 Approved
0.7788 Intermediate Similarity NPD5739 Approved
0.7788 Intermediate Similarity NPD6675 Approved
0.7788 Intermediate Similarity NPD6402 Approved
0.7778 Intermediate Similarity NPD4632 Approved
0.7767 Intermediate Similarity NPD4754 Approved
0.7767 Intermediate Similarity NPD5175 Approved
0.7767 Intermediate Similarity NPD5174 Approved
0.7692 Intermediate Similarity NPD5141 Approved
0.7684 Intermediate Similarity NPD5279 Phase 3
0.766 Intermediate Similarity NPD3133 Approved
0.766 Intermediate Similarity NPD3665 Phase 1
0.766 Intermediate Similarity NPD3666 Approved
0.7642 Intermediate Similarity NPD7320 Approved
0.7642 Intermediate Similarity NPD6899 Approved
0.7642 Intermediate Similarity NPD6881 Approved
0.7629 Intermediate Similarity NPD4753 Phase 2
0.7619 Intermediate Similarity NPD4767 Approved
0.7619 Intermediate Similarity NPD4768 Approved
0.757 Intermediate Similarity NPD6372 Approved
0.757 Intermediate Similarity NPD6373 Approved
0.7547 Intermediate Similarity NPD5701 Approved
0.7547 Intermediate Similarity NPD5697 Approved
0.7523 Intermediate Similarity NPD8297 Approved
0.75 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7290 Approved
0.75 Intermediate Similarity NPD6883 Approved
0.75 Intermediate Similarity NPD7102 Approved
0.7477 Intermediate Similarity NPD6011 Approved
0.7477 Intermediate Similarity NPD4729 Approved
0.7477 Intermediate Similarity NPD5128 Approved
0.7477 Intermediate Similarity NPD4730 Approved
0.7475 Intermediate Similarity NPD7515 Phase 2
0.7453 Intermediate Similarity NPD6008 Approved
0.7447 Intermediate Similarity NPD4221 Approved
0.7447 Intermediate Similarity NPD4223 Phase 3
0.7444 Intermediate Similarity NPD3703 Phase 2
0.7431 Intermediate Similarity NPD6617 Approved
0.7431 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD6869 Approved
0.7431 Intermediate Similarity NPD6649 Approved
0.7431 Intermediate Similarity NPD6847 Approved
0.7431 Intermediate Similarity NPD8130 Phase 1
0.7431 Intermediate Similarity NPD6650 Approved
0.7411 Intermediate Similarity NPD6009 Approved
0.7407 Intermediate Similarity NPD6012 Approved
0.7407 Intermediate Similarity NPD6013 Approved
0.7407 Intermediate Similarity NPD6014 Approved
0.74 Intermediate Similarity NPD6399 Phase 3
0.7396 Intermediate Similarity NPD5329 Approved
0.7391 Intermediate Similarity NPD3617 Approved
0.7368 Intermediate Similarity NPD6054 Approved
0.7368 Intermediate Similarity NPD6059 Approved
0.7368 Intermediate Similarity NPD6319 Approved
0.7364 Intermediate Similarity NPD6882 Approved
0.734 Intermediate Similarity NPD4139 Approved
0.734 Intermediate Similarity NPD4692 Approved
0.7339 Intermediate Similarity NPD5135 Approved
0.7339 Intermediate Similarity NPD5251 Approved
0.7339 Intermediate Similarity NPD5249 Phase 3
0.7339 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD5250 Approved
0.7339 Intermediate Similarity NPD5169 Approved
0.7339 Intermediate Similarity NPD5247 Approved
0.7339 Intermediate Similarity NPD5248 Approved
0.732 Intermediate Similarity NPD5690 Phase 2
0.732 Intermediate Similarity NPD5280 Approved
0.732 Intermediate Similarity NPD4694 Approved
0.7315 Intermediate Similarity NPD5168 Approved
0.7292 Intermediate Similarity NPD4197 Approved
0.7292 Intermediate Similarity NPD3668 Phase 3
0.7282 Intermediate Similarity NPD6083 Phase 2
0.7282 Intermediate Similarity NPD6084 Phase 2
0.7273 Intermediate Similarity NPD5217 Approved
0.7273 Intermediate Similarity NPD5215 Approved
0.7273 Intermediate Similarity NPD5127 Approved
0.7273 Intermediate Similarity NPD5216 Approved
0.7257 Intermediate Similarity NPD7115 Discovery
0.7255 Intermediate Similarity NPD5695 Phase 3
0.7255 Intermediate Similarity NPD4629 Approved
0.7255 Intermediate Similarity NPD5210 Approved
0.7248 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6370 Approved
0.7234 Intermediate Similarity NPD4748 Discontinued
0.7234 Intermediate Similarity NPD7525 Registered
0.7222 Intermediate Similarity NPD6412 Phase 2
0.7216 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7638 Approved
0.7204 Intermediate Similarity NPD6115 Approved
0.7204 Intermediate Similarity NPD6114 Approved
0.7204 Intermediate Similarity NPD6697 Approved
0.7204 Intermediate Similarity NPD6118 Approved
0.7188 Intermediate Similarity NPD4788 Approved
0.7179 Intermediate Similarity NPD7604 Phase 2
0.7157 Intermediate Similarity NPD7748 Approved
0.7155 Intermediate Similarity NPD5983 Phase 2
0.7155 Intermediate Similarity NPD6015 Approved
0.7155 Intermediate Similarity NPD6016 Approved
0.7143 Intermediate Similarity NPD7640 Approved
0.7143 Intermediate Similarity NPD4690 Approved
0.7143 Intermediate Similarity NPD7639 Approved
0.7143 Intermediate Similarity NPD4689 Approved
0.7143 Intermediate Similarity NPD4693 Phase 3
0.7143 Intermediate Similarity NPD5205 Approved
0.7143 Intermediate Similarity NPD4138 Approved
0.7143 Intermediate Similarity NPD4688 Approved
0.7129 Intermediate Similarity NPD5284 Approved
0.7129 Intermediate Similarity NPD5281 Approved
0.7119 Intermediate Similarity NPD7492 Approved
0.7111 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD5988 Approved
0.7091 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD5167 Approved
0.7065 Intermediate Similarity NPD6942 Approved
0.7065 Intermediate Similarity NPD7339 Approved
0.7059 Intermediate Similarity NPD6616 Approved
0.7059 Intermediate Similarity NPD6336 Discontinued
0.7043 Intermediate Similarity NPD6335 Approved
0.7018 Intermediate Similarity NPD6274 Approved
0.7018 Intermediate Similarity NPD6868 Approved
0.7009 Intermediate Similarity NPD7632 Discontinued
0.7 Intermediate Similarity NPD5737 Approved
0.7 Intermediate Similarity NPD6672 Approved
0.7 Intermediate Similarity NPD7078 Approved
0.7 Intermediate Similarity NPD8293 Discontinued
0.6989 Remote Similarity NPD6117 Approved
0.6983 Remote Similarity NPD7101 Approved
0.6983 Remote Similarity NPD7100 Approved
0.697 Remote Similarity NPD5330 Approved
0.697 Remote Similarity NPD7146 Approved
0.697 Remote Similarity NPD7521 Approved
0.697 Remote Similarity NPD6409 Approved
0.697 Remote Similarity NPD6684 Approved
0.697 Remote Similarity NPD7334 Approved
0.6957 Remote Similarity NPD6317 Approved
0.6952 Remote Similarity NPD7902 Approved
0.6942 Remote Similarity NPD6033 Approved
0.6942 Remote Similarity NPD7736 Approved
0.6923 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6917 Remote Similarity NPD7507 Approved
0.6915 Remote Similarity NPD6116 Phase 1
0.6897 Remote Similarity NPD6314 Approved
0.6897 Remote Similarity NPD6313 Approved
0.6893 Remote Similarity NPD5133 Approved
0.6889 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6889 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6887 Remote Similarity NPD5696 Approved
0.6875 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4695 Discontinued
0.6864 Remote Similarity NPD6909 Approved
0.6864 Remote Similarity NPD6908 Approved
0.6863 Remote Similarity NPD4096 Approved
0.6832 Remote Similarity NPD4518 Approved
0.6832 Remote Similarity NPD6903 Approved
0.6832 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7341 Phase 2
0.6809 Remote Similarity NPD6933 Approved
0.6809 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6796 Remote Similarity NPD8034 Phase 2
0.6796 Remote Similarity NPD6411 Approved
0.6796 Remote Similarity NPD6050 Approved
0.6796 Remote Similarity NPD8035 Phase 2
0.6778 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6778 Remote Similarity NPD5360 Phase 3
0.6774 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6774 Remote Similarity NPD5733 Approved
0.6771 Remote Similarity NPD4195 Approved
0.6765 Remote Similarity NPD6673 Approved
0.6765 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6765 Remote Similarity NPD6080 Approved
0.6765 Remote Similarity NPD6904 Approved
0.6754 Remote Similarity NPD6053 Discontinued
0.6748 Remote Similarity NPD7319 Approved
0.6733 Remote Similarity NPD7524 Approved
0.6733 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6733 Remote Similarity NPD3573 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data